Verseon's Anirban Datta Explains Challenges for Current Antiviral Drugs and Vaccines
Platform
Pipeline
About
News
Contact
Verseon's Anirban Datta Explains Challenges for Current Antiviral Drugs and Vaccines
News
Company suggests focusing on host-centric approach for a new class of antivirals as a lasting solution to combat SARS-CoV-2 and other viruses
January 11, 2022
News
Back to News